History and future of hepatitis B virus control in South Korea

키워드

참고문헌 (7)

1. Sarin SK, "Liver diseases in the Asia-Pacific region : a Lancet Gastroenterology & Hepatology commission", Lancet Gastroenterol Hepatol, 5, pp.167~228 (2020)
2. Yoon Jung-Hwan, "Epidemiological and Clinical History of Viral Hepatitis in Korea", Infection and Chemotherapy, 53(1), pp.159~165 (2021), 대한감염학회[DOI]
3. 임선영, "The epidemiology of hepatitis B virus infection in Korea", The Korean Journal of Internal Medicine, 34(5), pp.945~953 (2019), 대한내과학회[DOI]
4. Jeong S, "Differential effectiveness of tenofovir and entecavir for prophylaxis of hepatocellular carcinoma in chronic hepatitis B patients depending on coexisting cirrhosis and prior exposure to antiviral therapy : a systematic review and metaanalysis", J Clin Gastroenterol, 55, pp.e77~e86 (2021)
5. Baik D, "Costs of viral hepatitis B in the Republic of Korea, 2002-2015", J Viral Hepat, 27, pp.156~167 (2020)
6. Jourdain G, "Tenofovir versus placebo to prevent perinatal transmission of hepatitis B", N Engl J Med, 378, pp.911~923 (2018)
7. Cho ER, "Factors associated with use of ultrasonography screening for hepatocellular carcinoma among hepatitis B or C carriers", Cancer Epidemiol, 34, pp.713~716 (2010)

관련 논문AI추천